Kidney Dialysis Equipment Market Poised to Grow Substantially due to Rising Kidney Disease Burden
Kidney dialysis equipment is used to filter and clean blood when the kidneys are damaged or failed. Such equipment includes hemodialysis machines, bloodline systems, water treatment systems, dialyzers, and consumables among others. Kidney dialysis has become a life-supporting treatment for chronic kidney diseases and end-stage renal diseases globally. Rising prevalence of diabetes and hypertension as key risk factors for kidney diseases has fueled the demand for kidney dialysis equipment.
The global kidney dialysis equipment market is estimated to be valued at US$
16,874.5 million in 2024 and is expected to exhibit a CAGR of 6.6% over the
forecast period of 2023 to 2030.
Key Takeaways
Key players operating in the kidney dialysis equipment are Fresenius Medical
Care AG & Co, Baxter International, Inc., Nipro Corporation, B. Braun
Melsungen AG, Nikkiso Co, Ltd., Asahi Kasei Corporation, NxStage Medical, Inc.,
Guangdong Biolight Meditech Co., Ltd, Dialife SA, and DaVita Inc. These players
are focusing on new product launches, expansions, acquisitions and approvals to
strengthen their product portfolios and global presence.
The key opportunities in the kidney
dialysis equipment market include growing preference for home-based
dialysis as it offers flexibility and convenient treatment. This has prompted
players to focus on developing portable kidney dialysis equipment suitable for
home use. Moreover, increasing healthcare spending in developing nations is
anticipated to boost market growth during the forecast period.
Global expansion is another area players are focused on. Manufacturers are
actively looking to enter high growth emerging markets in Asia Pacific, Latin
America, Middle East and Africa through partnerships and acquisitions owing to
increasing patient base in these regions. This will help them expand their
global footprints and access new customer segments.
Market Drivers:
The rising prevalence of end-stage renal disease (ESRD) is a major factor
fueling the kidney dialysis equipment market growth. According to the data,
ESRD prevalence has grown significantly over the past decade globally. Other
factors such as growing geriatric population, increasing incidence of
lifestyle-related diseases like diabetes and hypertension, improved reimbursement
policies for dialysis therapies and technological advancements in dialysis
equipment are also boosting the market.
Market Restrains:
High cost of kidney dialysis equipment and procedures can hamper the market
growth. The dialysis equipment being life-supporting devices are very
expensive, which restricts many patients from opting for such therapies. Lack
of skilled professionals in underdeveloped nations and stringent regulatory
framework for dialysis equipment approval are other challenges that can affect
market potential in developing regions.
The kidney dialysis equipment market is dominated by the hemodialysis segment. Hemodialysis equipment accounts for the largest market share as it is the most common type of dialysis used to treat kidney failure and end stage renal diseases. It is preferred by healthcare providers due to its effectiveness in removing waste and excess fluid from the blood and managing disorders. Furthermore, technological advances have made hemodialysis equipment more convenient and improved its efficacy through portable machines and home dialysis solutions.
Global Analysis
North America holds the major share in the kidney dialysis equipment market owing to the rising prevalence of diabetes, hypertension and chronic kidney diseases in the region. The favorable reimbursement policies and presence of prominent players are also contributing to the market growth. The Asia Pacific region is expected to grow at the fastest rate during the forecast period due to growing awareness, increasing healthcare spending and expanding medical tourism industry. Improvements in healthcare infrastructure in emerging economies provide opportunities for kidney dialysis equipment manufacturers. However, high costs associated and complex regulatory frameworks remain challenges.

Comments
Post a Comment